ID SMRCD_MOUSE Reviewed; 1021 AA. AC Q04692; Q3UGK6; Q3UYR6; DT 28-MAR-2003, integrated into UniProtKB/Swiss-Prot. DT 28-MAR-2003, sequence version 2. DT 27-MAR-2024, entry version 188. DE RecName: Full=SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1; DE EC=3.6.4.12; DE AltName: Full=ATP-dependent helicase SMARCAD1; DE AltName: Full=Enhancer trap locus homolog 1; DE Short=Etl-1; GN Name=Smarcad1; Synonyms=Etl1, Kiaa1122; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J; TISSUE=Embryo; RX PubMed=1489724; DOI=10.1016/0925-4773(92)90030-n; RA Soininen R., Schoor M., Henseling U., Tepe C., Kisters-Woike B., RA Rossant J., Gossler A.; RT "The mouse Enhancer trap locus 1 (Etl-1): a novel mammalian gene related to RT Drosophila and yeast transcriptional regulator genes."; RL Mech. Dev. 39:111-123(1992). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=12693553; DOI=10.1093/dnares/10.1.35; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., RA Nakajima D., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: II. RT The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:35-48(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=FVB/N; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-760. RC STRAIN=C57BL/6J; TISSUE=Testis; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [5] RP SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE. RX PubMed=8219362; DOI=10.1002/aja.1001970307; RA Schoor M., Schuster-Gossler K., Gossler A.; RT "The Etl-1 gene encodes a nuclear protein differentially expressed during RT early mouse development."; RL Dev. Dyn. 197:227-237(1993). RN [6] RP DISRUPTION PHENOTYPE. RX PubMed=10415348; DOI=10.1016/s0925-4773(99)00090-8; RA Schoor M., Schuster-Gossler K., Roopenian D., Gossler A.; RT "Skeletal dysplasias, growth retardation, reduced postnatal survival, and RT impaired fertility in mice lacking the SNF2/SWI2 family member ETL1."; RL Mech. Dev. 85:73-83(1999). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Teratocarcinoma; RX PubMed=17622165; DOI=10.1021/pr070122r; RA Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; RT "A differential phosphoproteomic analysis of retinoic acid-treated P19 RT cells."; RL J. Proteome Res. 6:3174-3186(2007). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144 AND SER-145, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [9] RP SUBCELLULAR LOCATION. RX PubMed=18675275; DOI=10.1016/j.jmb.2008.07.031; RA Okazaki N., Ikeda S., Ohara R., Shimada K., Yanagawa T., Nagase T., RA Ohara O., Koga H.; RT "The novel protein complex with SMARCAD1/KIAA1122 binds to the vicinity of RT TSS."; RL J. Mol. Biol. 382:257-265(2008). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-127; SER-144; RP SER-145 AND SER-151, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Pancreas, RC Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [11] RP SUBCELLULAR LOCATION. RX PubMed=21549307; DOI=10.1016/j.molcel.2011.02.036; RA Rowbotham S.P., Barki L., Neves-Costa A., Santos F., Dean W., Hawkes N., RA Choudhary P., Will W.R., Webster J., Oxley D., Green C.M., Varga-Weisz P., RA Mermoud J.E.; RT "Maintenance of silent chromatin through replication requires SWI/SNF-like RT chromatin remodeler SMARCAD1."; RL Mol. Cell 42:285-296(2011). CC -!- FUNCTION: DNA helicase that possesses intrinsic ATP-dependent CC nucleosome-remodeling activity and is both required for DNA repair and CC heterochromatin organization. Promotes DNA end resection of double- CC strand breaks (DSBs) following DNA damage: probably acts by weakening CC histone DNA interactions in nucleosomes flanking DSBs. Required for the CC restoration of heterochromatin organization after replication. Acts at CC replication sites to facilitate the maintenance of heterochromatin by CC directing H3 and H4 histones deacetylation, H3 'Lys-9' trimethylation CC (H3K9me3) and restoration of silencing (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; CC -!- SUBUNIT: Binds to DNA preferentially in the vicinity of transcriptional CC start sites. Interacts with MSH2 and TRIM28. Part of a complex composed CC of TRIM28, HDAC1, HDAC2 and EHMT2. Interacts with PCNA (By similarity). CC {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18675275, CC ECO:0000269|PubMed:21549307, ECO:0000269|PubMed:8219362}. Chromosome CC {ECO:0000250}. Note=Colocalizes with PCNA at replication forks during S CC phase. Recruited to double-strand breaks (DSBs) sites of DNA damage (By CC similarity). {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q04692-1; Sequence=Displayed; CC Name=2; CC IsoId=Q04692-2; Sequence=VSP_007080; CC -!- DEVELOPMENTAL STAGE: Detected at low levels in fertilized and CC unfertilized eggs. Levels increased in two-cell embryos, decreased up CC to morula stage and were highest in blastocysts. Highly expressed in CC the inner cell mass of 3.5 day old blastocysts. Highly expressed in CC ectoderm and visceral endoderm at day 5.5. Detected throughout the CC brain and spinal cord at day 10 to 15. Detected in the basal layer of CC the epidermis after day 12.5, in particular on snout and distal on CC fore- and hindlimbs. {ECO:0000269|PubMed:8219362}. CC -!- DISRUPTION PHENOTYPE: Deficient mice have reduced viability and show CC growth retardation, skeletal dysplasia and impaired fertility. CC {ECO:0000269|PubMed:10415348}. CC -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC65736.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=CAA49560.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X69942; CAA49560.1; ALT_INIT; mRNA. DR EMBL; AK122454; BAC65736.1; ALT_INIT; mRNA. DR EMBL; BC042442; AAH42442.1; -; mRNA. DR EMBL; AK134442; BAE22146.1; -; mRNA. DR EMBL; AK147884; BAE28202.1; -; mRNA. DR CCDS; CCDS20204.1; -. [Q04692-1] DR PIR; A56559; A56559. DR RefSeq; NP_001240321.1; NM_001253392.1. [Q04692-2] DR RefSeq; NP_031984.1; NM_007958.1. [Q04692-1] DR RefSeq; XP_006505572.1; XM_006505509.3. DR RefSeq; XP_006505573.1; XM_006505510.2. [Q04692-1] DR RefSeq; XP_006505575.1; XM_006505512.3. [Q04692-2] DR RefSeq; XP_011239507.1; XM_011241205.2. DR AlphaFoldDB; Q04692; -. DR SMR; Q04692; -. DR BioGRID; 199524; 8. DR STRING; 10090.ENSMUSP00000031984; -. DR ChEMBL; CHEMBL4879452; -. DR iPTMnet; Q04692; -. DR PhosphoSitePlus; Q04692; -. DR EPD; Q04692; -. DR jPOST; Q04692; -. DR MaxQB; Q04692; -. DR PaxDb; 10090-ENSMUSP00000031984; -. DR PeptideAtlas; Q04692; -. DR ProteomicsDB; 261280; -. [Q04692-1] DR ProteomicsDB; 261281; -. [Q04692-2] DR Pumba; Q04692; -. DR Antibodypedia; 14709; 159 antibodies from 26 providers. DR DNASU; 13990; -. DR Ensembl; ENSMUST00000031984.9; ENSMUSP00000031984.7; ENSMUSG00000029920.10. [Q04692-1] DR GeneID; 13990; -. DR KEGG; mmu:13990; -. DR UCSC; uc009ced.1; mouse. [Q04692-1] DR AGR; MGI:95453; -. DR CTD; 56916; -. DR MGI; MGI:95453; Smarcad1. DR VEuPathDB; HostDB:ENSMUSG00000029920; -. DR eggNOG; KOG0389; Eukaryota. DR GeneTree; ENSGT00910000144252; -. DR HOGENOM; CLU_000315_16_3_1; -. DR InParanoid; Q04692; -. DR OMA; MEMRRMA; -. DR OrthoDB; 5482994at2759; -. DR PhylomeDB; Q04692; -. DR TreeFam; TF105768; -. DR BioGRID-ORCS; 13990; 7 hits in 121 CRISPR screens. DR ChiTaRS; Smarcad1; mouse. DR PRO; PR:Q04692; -. DR Proteomes; UP000000589; Chromosome 6. DR RNAct; Q04692; Protein. DR Bgee; ENSMUSG00000029920; Expressed in undifferentiated genital tubercle and 285 other cell types or tissues. DR ExpressionAtlas; Q04692; baseline and differential. DR GO; GO:0000792; C:heterochromatin; IDA:UniProtKB. DR GO; GO:0043596; C:nuclear replication fork; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0035861; C:site of double-strand break; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA. DR GO; GO:0008094; F:ATP-dependent activity, acting on DNA; IBA:GO_Central. DR GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; ISS:UniProtKB. DR GO; GO:0003682; F:chromatin binding; IBA:GO_Central. DR GO; GO:0003677; F:DNA binding; ISO:MGI. DR GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW. DR GO; GO:0043130; F:ubiquitin binding; IEA:InterPro. DR GO; GO:0006338; P:chromatin remodeling; ISO:MGI. DR GO; GO:0051304; P:chromosome separation; ISS:UniProtKB. DR GO; GO:0000729; P:DNA double-strand break processing; ISS:UniProtKB. DR GO; GO:0000018; P:regulation of DNA recombination; ISS:UniProtKB. DR CDD; cd17998; DEXHc_SMARCAD1; 1. DR CDD; cd18793; SF2_C_SNF; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1. DR InterPro; IPR003892; CUE. DR InterPro; IPR014001; Helicase_ATP-bd. DR InterPro; IPR001650; Helicase_C. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR038718; SNF2-like_sf. DR InterPro; IPR049730; SNF2/RAD54-like_C. DR InterPro; IPR000330; SNF2_N. DR PANTHER; PTHR10799; SNF2/RAD54 HELICASE FAMILY; 1. DR PANTHER; PTHR10799:SF964; SWI_SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A CONTAINING DEAD_H BOX 1; 1. DR Pfam; PF00271; Helicase_C; 1. DR Pfam; PF00176; SNF2-rel_dom; 1. DR SMART; SM00487; DEXDc; 1. DR SMART; SM00490; HELICc; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2. DR PROSITE; PS51140; CUE; 2. DR PROSITE; PS51192; HELICASE_ATP_BIND_1; 1. DR PROSITE; PS51194; HELICASE_CTER; 1. DR Genevisible; Q04692; MM. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; ATP-binding; Chromatin regulator; KW Chromosome; DNA damage; DNA repair; DNA-binding; Helicase; Hydrolase; KW Isopeptide bond; Nucleotide-binding; Nucleus; Phosphoprotein; KW Reference proteome; Repeat; Ubl conjugation. FT CHAIN 1..1021 FT /note="SWI/SNF-related matrix-associated actin-dependent FT regulator of chromatin subfamily A containing DEAD/H box 1" FT /id="PRO_0000074357" FT DOMAIN 156..198 FT /note="CUE 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00468" FT DOMAIN 247..290 FT /note="CUE 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00468" FT DOMAIN 504..672 FT /note="Helicase ATP-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT DOMAIN 853..1005 FT /note="Helicase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00542" FT REGION 1..82 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 124..151 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 201..246 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 329..366 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 623..626 FT /note="DEGH box" FT MOTIF 716..733 FT /note="Nuclear localization signal" FT /evidence="ECO:0000255" FT MOTIF 1000..1003 FT /note="DEAD box" FT COMPBIAS 44..72 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 208..237 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 516..524 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT BINDING 892..899 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 54 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 57 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 79 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 124 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 127 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 132 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 144 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355, FT ECO:0007744|PubMed:21183079" FT MOD_RES 145 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355, FT ECO:0007744|PubMed:21183079" FT MOD_RES 151 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 210 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 213 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 235 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 238 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT MOD_RES 298 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT CROSSLNK 77 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT CROSSLNK 330 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT CROSSLNK 466 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT CROSSLNK 719 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT CROSSLNK 991 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q9H4L7" FT VAR_SEQ 1..185 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_007080" FT CONFLICT 857 FT /note="I -> S (in Ref. 1; CAA49560)" FT /evidence="ECO:0000305" SQ SEQUENCE 1021 AA; 116451 MW; E3237AA2B135538A CRC64; MNLFNLDRFR FEKRSKIEEA PEAAPQPSQA RPSSPISLSA EEENAEGEGS RANTPDSDVT EKTEDSSVPE PPDNERKASL SCFQNQRAIQ EYIDLSSDTE DVSPNCSSTV QEKKFSKDTV IIVSEPSEDE ESHDLPSVTR RNDSSELEDL SELEDLKDAK LQTLKELFPQ RSDSDLLKLI ESTSTMDGAI AAALLMFGDA GGGPRKRKLS SSSEEDDVND DQSVKQPRGD RGEESNESAE ASSNWEKQES IVLKLQKEFP NFDKQELREV LKEHEWMYTE ALESLKVFAE DQDVQCASQS EVTNGKEVAR NQNYSKNATK IKMKQKISVK PQNGFNKKRK KNVFNPKKAV EDSEYDSGSD AGSSLDEDYS SCEEVMEDGY KGKILHFLQV SSIAELTLIP KCSQKKAQKI TELRPFNNWE ALFTKMSKIN GLSEDLIWNC KTVIQERDVV IRLMNKCEDI SNKLTKQVTM LTGNGGGWNR EQPSLLNQSL SLKPYQKVGL NWLALVHKHG LNGILADEMG LGKTIQAIAF LAYLFQEGNK GPHLIVVPAS TIDNWLREVN LWCPSLNVLC YYGSQEERKQ IRFNIHNKYE DYNVIVTTYN CAISSSDDRS LFRRLKLNYA IFDEGHMLKN MGSIRYQHLM TINARNRLLL TGTPVQNNLL ELMSLLNFVM PHMFSSSTSE IRRMFSSKTK PADEQSIYEK ERIAHAKQII KPFILRRVKE EVLKLLPPKK DRIELCAMSE KQEQLYSGLF NRLKKSINNL EKNTEMCNVM MQLRKMANHP LLHRQYYTPE KLKEMSQLML KEPTHCEANP DLIFEDMEVM TDFELHVLCK QYQHINSYQL DMDLILDSGK FRALGCILSE LKQKGDRVVL FSQFTMMLDI LEVLLKHHQH RYLRLDGKTQ ISERIHLIDE FNTDMDIFVF LLSTKAGGLG INLTSANVVI LHDIDCNPYN DKQAEDRCHR VGQTKEVLVI KLISQGTIEE SMLKINQQKL KLEQDMTTVD EADEGSMPAD IATLLKTSMG L //